Principal Financial Group Inc. Boosts Stake in GE HealthCare Technologies Inc. $GEHC

Principal Financial Group Inc. increased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.1% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 554,183 shares of the company’s stock after purchasing an additional 11,484 shares during the period. Principal Financial Group Inc. owned 0.12% of GE HealthCare Technologies worth $45,454,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in GEHC. Capital Research Global Investors lifted its holdings in shares of GE HealthCare Technologies by 25.0% in the 3rd quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock valued at $1,875,400,000 after purchasing an additional 4,998,154 shares during the last quarter. Dodge & Cox lifted its holdings in shares of GE HealthCare Technologies by 16.8% in the 3rd quarter. Dodge & Cox now owns 27,517,311 shares of the company’s stock valued at $2,066,550,000 after purchasing an additional 3,949,361 shares during the last quarter. Boston Partners purchased a new stake in shares of GE HealthCare Technologies in the 3rd quarter valued at about $287,627,000. Temasek Holdings Private Ltd purchased a new stake in shares of GE HealthCare Technologies in the 3rd quarter valued at about $99,922,000. Finally, Hotchkis & Wiley Capital Management LLC lifted its holdings in shares of GE HealthCare Technologies by 17.1% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 8,432,374 shares of the company’s stock valued at $633,271,000 after purchasing an additional 1,232,828 shares during the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at GE HealthCare Technologies

In related news, CEO Peter J. Arduini bought 4,169 shares of the stock in a transaction on Thursday, April 30th. The shares were purchased at an average price of $59.92 per share, for a total transaction of $249,806.48. Following the acquisition, the chief executive officer owned 259,424 shares in the company, valued at $15,544,686.08. This represents a 1.63% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Frank R. Jimenez bought 1,750 shares of the stock in a transaction on Thursday, April 30th. The shares were bought at an average price of $60.45 per share, for a total transaction of $105,787.50. Following the acquisition, the insider owned 93,932 shares in the company, valued at $5,678,189.40. The trade was a 1.90% increase in their position. The SEC filing for this purchase provides additional information. In the last 90 days, insiders have purchased 9,229 shares of company stock worth $556,180. 0.36% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several research firms have commented on GEHC. Citigroup reduced their price objective on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating for the company in a research note on Thursday, April 30th. Barclays dropped their target price on GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 30th. JPMorgan Chase & Co. lowered their price target on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a report on Thursday, April 30th. Wall Street Zen cut GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, March 21st. Finally, Jefferies Financial Group lowered their price target on GE HealthCare Technologies from $105.00 to $90.00 in a report on Thursday, April 30th. Eight equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $80.67.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC opened at $63.47 on Friday. The business’s fifty day moving average price is $71.92 and its two-hundred day moving average price is $77.34. The stock has a market cap of $28.87 billion, a PE ratio of 15.18, a price-to-earnings-growth ratio of 1.38 and a beta of 0.74. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22. GE HealthCare Technologies Inc. has a one year low of $58.75 and a one year high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The company had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. GE HealthCare Technologies’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter last year, the company posted $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, analysts forecast that GE HealthCare Technologies Inc. will post 4.89 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be issued a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio is 3.35%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.